Distant Metastasis of Patients During Fifteen Month Follow-Up Period | ||||
Metastasis | Group | Fisher’s Exact test | p-value | |
PDS* N (%) | IDS* N (%) | |||
At first follow-up |
|
|
|
|
Peritoneal | 0 (0.0) | 0 (0.0) |
|
|
At 6 months follow-up |
|
|
|
|
Peritoneal | 03 (10.3) | 0 (0.0) | 3.273 | 0.11 |
At 9 months follow-up |
|
|
|
|
Liver | 01 (3.4) | 0 (0.0) | 2.422 | 0.425 |
Peritoneal | 03 (10.3) | 02 (6.7) | ||
Supraclavicular | 01 (3.4) | 0 (0.0) | ||
At 12 months follow-up |
|
|
|
|
Liver | 01 (3.4) | 0 (0.0) | 2.422 | 0.425 |
Peritoneal | 03 (10.3) | 2 (6.7) | ||
Supraclavicular | 01 (3.4) | 0 (0.0) | ||
At 15 months follow-up |
|
|
|
|
Lung | 01 (3.4) | 0 (0.0) |
|
|
Liver | 02 (6.9) | 0 (0.0) | 4.878 | 0.258 |
Peritoneal | 03 (10.3) | 01 (3.3) |
|
|
Supraclavicular | 02 (6.9) | 0 (0.0) |
|
|
TOTAL RECURENCES | 21 (70%) | 5 (16.7%) |
|
|